| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/29/2005 | WO2005123123A2 Therapeutic reprogramming, hybrid stem cells and maturation |
| 12/29/2005 | WO2005123116A2 Compositions and methods for treating or preventing oxalate-related disease |
| 12/29/2005 | WO2005123100A1 Lactic bacteria and their use in the prevention of diarrhea |
| 12/29/2005 | WO2005123099A2 Methods and compositions for accelerating alcohol metabolism |
| 12/29/2005 | WO2005122794A1 Composition containing plant extract and material derived from milk |
| 12/29/2005 | WO2005046587A3 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 12/29/2005 | WO2005046560A3 Glans compatible single unit semen collection and storage device, kit and related methods of use |
| 12/29/2005 | WO2005035733A3 Modified whole cell, cell extract and omv-based vaccines |
| 12/29/2005 | WO2005023996A3 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 12/29/2005 | WO2004094599A3 Disease prevention and vaccination following thymic reactivation |
| 12/29/2005 | US20050288239 Anticancer glycoside compounds |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050287657 Method for producing recombinant adenovirus |
| 12/29/2005 | US20050287581 Gene sequence of alpha(1,3)galactosyltransferase |
| 12/29/2005 | US20050287530 TCL-1b gene and protein and related methods and compositions |
| 12/29/2005 | US20050287222 Method for producing water containing extracted ingredients from plant, animal, or mineral matter |
| 12/29/2005 | US20050287168 Recombinant spores |
| 12/29/2005 | US20050287162 Recombinant fowlpox virus |
| 12/29/2005 | US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide |
| 12/29/2005 | US20050287145 Compositions and methods for producing vascular occlusion |
| 12/29/2005 | US20050287127 Use of stem cells to generate inner ear cells |
| 12/29/2005 | US20050287124 Method for inducing bone marrow-derived cells in injured epithelial site and a method for repairing injured epithelium |
| 12/29/2005 | US20050287123 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof |
| 12/29/2005 | US20050287120 Cancer - targeted viral vectors |
| 12/29/2005 | US20050287116 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
| 12/29/2005 | US20050287092 Cosmetic powder comprising barium sulfate |
| 12/29/2005 | DE102004045187A1 Wirkstoff, der in der Lage ist, die Überführung von inaktivem TGFb-latent in aktiven TGFb zu induzieren Agent that is capable of inducing the conversion of inactive latent TGFb-in active TGFb |
| 12/29/2005 | DE102004028144A1 Using extracts (containing marine thistle weeds, pancreatin and cape aloe) for the treatment of digestive complaints and/or diseases of the digestive tract and halitosis |
| 12/29/2005 | CA2612146A1 Treating cancer |
| 12/29/2005 | CA2567975A1 Stem cell maturation for all tissue lines |
| 12/29/2005 | CA2567692A1 Therapeutic reprogramming, hybrid stem cells and maturation |
| 12/29/2005 | CA2565972A1 Ex-vivo application of solid microparticulate therapeutic agents |
| 12/28/2005 | EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP) |
| 12/28/2005 | EP1609852A1 Bifidobacteria and preparations containing them |
| 12/28/2005 | EP1609802A1 Transcriptional factor inducing apoptosis in cancer cell |
| 12/28/2005 | EP1609463A1 Process and compositions for the protection and/or the treatment of dry and/or sensitive skin |
| 12/28/2005 | EP1608737A1 Lactobacillus fermentum strain and uses thereof |
| 12/28/2005 | EP1608728A2 Materials and methods for regulating process formation in cell culture |
| 12/28/2005 | EP1608411A2 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 12/28/2005 | EP1608391A2 Composition for inducing of immunotolerance |
| 12/28/2005 | EP1608389A1 Active ingredient combinations of plant oils containing omega-3 fatty acids and plant extracts containing isoprenoids and the use thereof |
| 12/28/2005 | EP1608386A1 Compositions comprising omega-3 fatty acid-containing oils and plant extracts |
| 12/28/2005 | EP1608384A2 Therapy for primary and metastatic cancers |
| 12/28/2005 | EP1608383A1 A formulation comprising a bacterial strain |
| 12/28/2005 | EP1608382A1 Process for the staining of sperm |
| 12/28/2005 | EP1608369A2 Use of organic compounds for immunopotentiation |
| 12/28/2005 | EP1608355A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 12/28/2005 | EP1608314A2 Novel probiotic compositions and methods of using the same |
| 12/28/2005 | EP1608308A2 Anti-inflammatory activity from lactic acid bacteria |
| 12/28/2005 | EP1608232A2 Method and compositions for improving animal health |
| 12/28/2005 | EP1575572A3 Collagen biofabric and methods of preparation and use therefor |
| 12/28/2005 | EP1495109B1 Method of preparing a probiotic preparation |
| 12/28/2005 | EP1317489B1 A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy |
| 12/28/2005 | EP1206242B1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 12/28/2005 | EP1073683B1 G-csf receptor agonist antibodies and screening method therefor |
| 12/28/2005 | EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 12/28/2005 | EP1053302B1 Expanded and genetically modified populations of human hematopoietic stem cells |
| 12/28/2005 | EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 12/28/2005 | EP0879281B1 Methods for transforming dendritic cells and activating t cells |
| 12/28/2005 | EP0797676B1 Recombinant adenoviral vector and methods of use |
| 12/28/2005 | EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 12/28/2005 | CN1713861A Vascularization enhanced graft constructs |
| 12/28/2005 | CN1712022A Process and compositions for the protection and/or the treatment of dry and/or sensitive skin |
| 12/28/2005 | CN1712021A Chinese medicines for treating diseases of prostatic hyperplasia and urinary system and gynecopathy |
| 12/28/2005 | CN1712020A Production of amniotic extractive liquid and use thereof |
| 12/28/2005 | CN1712019A Production of solid superfine pilose antler powder |
| 12/28/2005 | CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| 12/28/2005 | CN1233400C Fever bringing down formulation for preventing virus and its prepn. method |
| 12/28/2005 | CN1233373C Chinese medicine composition for treating spondylodynia |
| 12/28/2005 | CN1233330C Extraction of Malassezia for treating chlosma, said prepn. and its prepn. method and application thereof |
| 12/28/2005 | CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis |
| 12/27/2005 | US6979677 Inhibition of vascular smooth muscle cell proliferation |
| 12/27/2005 | US6979572 a modified tertiapin peptide containing a stable tertiapin derivative wherein the methionine residue in position 13 of tertiapin is replaced by glutamine. controls insulin secretion, cardiac rhythm, electrical conduction |
| 12/27/2005 | US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/22/2005 | WO2005121343A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 12/22/2005 | WO2005121323A2 Methods for ex vivo propagation of somatic hair follicle stem cells |
| 12/22/2005 | WO2005121321A2 Compositions comprising female germline stem cells and methods of use thereof |
| 12/22/2005 | WO2005121320A1 Autonomouos replication promoter for stem cells |
| 12/22/2005 | WO2005121318A2 Neural stem cells |
| 12/22/2005 | WO2005121316A1 Tissue material and muscle derived matrix |
| 12/22/2005 | WO2005121312A1 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 12/22/2005 | WO2005120579A1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |
| 12/22/2005 | WO2005120560A1 Bacterial compositions for the treatment of cancer |
| 12/22/2005 | WO2005120541A1 Process for producing protein having its antihypertensive activity enhanced |
| 12/22/2005 | WO2005120527A1 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 12/22/2005 | WO2005120526A1 Composition for inhibiting the progress of muscular dystrophy |
| 12/22/2005 | WO2005120525A1 Pharmaceutical active substance extracted from lycosa tarantula |
| 12/22/2005 | WO2005120522A1 Rheumatism preventive or therapeutic agent and beverage each comprising reduced-deuterium water |
| 12/22/2005 | WO2005120452A1 A procedure in production of a curative creams for regeneration of skin tissue, easer breathing, psoriasis, pains and tiredness in legs |
| 12/22/2005 | WO2005120366A2 Periosteal distraction |
| 12/22/2005 | WO2005120255A1 Process for producing chlorophyll-containing substance |
| 12/22/2005 | WO2005120250A1 Unique manuka factor (umf) fortified honey |
| 12/22/2005 | WO2005103080A3 Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof |
| 12/22/2005 | US20050283849 Capsules containing vital cells or tissues |
| 12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/22/2005 | US20050282735 Von Willebrand Factor (VWF); prevents a bleeding diathesis and reduces pre-, peri- and postoperative blood loss in acquired Von Willebrand syndromes such as in cardiovascular diseases requiring surgical procedures |
| 12/22/2005 | US20050282280 Oncolytic adenoviral vectors encoding GM-CSF |
| 12/22/2005 | US20050282277 Methods of increasing platelet and hematopoietic stem cell production |
| 12/22/2005 | US20050282276 Cell fractions containing cells capable of differentiating into neural cells |
| 12/22/2005 | US20050282275 Adipose-derived stem cells and lattices |